Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Alfa Laval | ALFA | 21. nov 2024 | 476.50 | +2.19 |
Alimak Group | ALIG | 21. nov 2024 | 118.00 | +1.55 |
Alleima AB | ALLEI | 21. nov 2024 | 70.65 | +0.64 |
Alligator Bioscience | ATORX | 21. nov 2024 | 0.55 | +10.14 |
Alligo B | ALLIGOB | 21. nov 2024 | 120.60 | -0.82 |
ALM Equity | ALM | 21. nov 2024 | 172.00 | -1.15 |
ALM Equity Pref | ALMPREF | 21. nov 2024 | 86.90 | -0.11 |
Alpcot Holding B | ALPCOTB | 21. nov 2024 | 0.61 | +1.65 |
Alteco | ALTE | 21. nov 2024 | 0.16 | -0.64 |
AlzeCure Pharma | ALZCUR | 21. nov 2024 | 1.00 | -10.67 |
Alzinova | ALZ | 21. nov 2024 | 3.70 | 0.00 |
Ambea | AMBEA | 21. nov 2024 | 93.20 | +0.43 |
Amhult 2 B | AMH2B | 21. nov 2024 | 54.50 | -3.54 |
Amido | AMIDO | 21. nov 2024 | 2.00 | 0.00 |
Amniotics | AMNI | 21. nov 2024 | 0.01 | 0.00 |
Angler Gaming | ANGL | 21. nov 2024 | 4.00 | +2.56 |
Annehem Fastigheter B | ANNEB | 21. nov 2024 | 16.80 | -0.59 |
Annexin Pharmaceuticals | ANNX | 21. nov 2024 | 0.47 | -1.67 |
Anoto Group | ANOT | 21. nov 2024 | 0.19 | +9.25 |
ANTCO. Investment Group | ANTCOB | 21. nov 2024 | 0.07 | +7.14 |
Appspotr | APTR | 21. nov 2024 | 0.19 | +0.26 |
Aprendere Skolor | APRNDR | 21. nov 2024 | 11.10 | -0.89 |
Aptahem | APTA | 21. nov 2024 | 1.38 | +7.81 |
AQ Group | AQ | 21. nov 2024 | 141.10 | +0.36 |
Aquaticus Real Estate | AQUAT | 21. nov 2024 | 62.00 | 0.00 |
Arbona A | ARBOA | 21. nov 2024 | 3.18 | +1.92 |
Arcario | ARCA | 21. nov 2024 | 0.02 | -2.17 |
Archelon Natural Resources | ALONNRB | 21. nov 2024 | 0.50 | -23.66 |
Arcoma | ARCOMA | 21. nov 2024 | 10.95 | +5.80 |
Arctic Blue Beverages AB | ARCTIC | 21. nov 2024 | 0.14 | -2.76 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.